Integrated Research Limited provided revenue guidance for the full year 2023. Subject to audit, the company expected the TCV result to translate into reported statutory revenue in the range of $39 million - $42 million for the period, an increase of 1% - 9% on the pcp. On a pro-forma basis, revenue is anticipated to be in the range of $36 million - $38 million, down -6% - 0% on the pcp, reflecting lower recurring (licence) revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 AUD | +4.29% |
|
+14.96% | +102.78% |
May. 10 | Integrated Research's Shares Surge More Than 50% on Upbeat Guidance | MT |
Mar. 06 | Cathy Aston Resigns as Director of Integrated Research Limited, Effective 31 March 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+102.78% | 80.82M | |
+17.69% | 3,289B | |
+14.62% | 90.43B | |
+14.59% | 85.57B | |
+37.27% | 52.49B | |
-20.36% | 50.25B | |
+32.93% | 46.79B | |
+83.75% | 42.74B | |
-32.70% | 41.67B | |
-1.24% | 27.82B |
- Stock Market
- Equities
- IRI Stock
- News Integrated Research Limited
- Integrated Research Limited Provides Revenue Guidance for the Full Year 2023